No Data
No Data
Market Might Still Lack Some Conviction On Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) Even After 45% Share Price Boost
Guiyang Xintian Pharmaceutical Co.,Ltd. (SZSE:002873) shares have had a really impressive month, gaining 45% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since th
Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Most Bullish Insider, CEO Da Lun Dong Must Be Pleased With the Recent 21% Gain
Key Insights Significant insider control over Guiyang Xintian PharmaceuticalLtd implies vested interests in company growth The top 7 shareholders own 50% of the company 18% of Guiyang Xintian Pha
Gelonghui Announcement Selection | Huarong Chemical: Net profit increased by 13.53% to 139 million yuan in 2023, and plans to pay 10 to 2 yuan; Shanghai Industrial: Satellite components-related business and robot system integration business account for re
[Hot Focus] Shanghai Shanghai Industrial (603131.SH): The satellite component-related business and robot system integration business account for a relatively small share of the revenue. Currently, the company's main business has not changed. Shanghai Shanghaihang Satellite Technology Co., Ltd., a wholly-owned subsidiary of the company, is involved in some satellite component-related businesses, and its revenue accounts for about 1%-2% of the listed companies' revenue; the company is involved in robot system integration, and the revenue accounts for about 1%-2% of the listed company's revenue. 603131.SH Satellite component-related business and robot system integration business account for relatively small revenue
Xintian Pharmaceutical (002873.SZ): Trading of the company's shares and convertible bonds will resume on March 8
Gelonghui, March 7, 丨 Xintian Pharmaceutical (002873.SZ) announced that following the company's application to the Shenzhen Stock Exchange, trading of the company's shares and convertible corporate bonds will resume trading from the opening of the market on March 8, 2024 (Friday), and convertible corporate bonds will resume conversion on the same day.
Xintian Pharmaceutical (002873.SZ): Plans to purchase 85.12% of Huilun Pharmaceutical's shares
On March 7, Gelonghui | Xintian Pharmaceutical (002873.SZ) announced that it plans to purchase 85.12% of Huilun Pharmaceutical's shares held by 88 Huilun Pharmaceutical shareholders, including Dong Dalun, Dong Zhu, and Hainan Qianyao, through the issuance of shares. After the transaction is completed, Huilun Pharmaceutical will become a wholly-owned subsidiary of the listed company. This transaction does not involve raising supporting funds. After the audit and evaluation work relating to the underlying asset is completed, the listed company will sign a supplementary agreement with the counterparty to issue shares and purchase assets, confirm the final transaction price and transaction plan, and disclose it in the restructuring report. What is Huilun Pharmaceutical's main business
Xintian Pharmaceutical (002873.SZ): 3.8037% of shares have been cumulatively repurchased
Gelonghui, March 1, 丨 Xintian Pharmaceutical (002873.SZ) announced that as of February 29, 2024, the company had repurchased a total of 8,806,030 shares through a special share repurchase account, accounting for 3.8037% of the company's total share capital of 231,514,155 shares on February 29, 2024. The maximum transaction price was 9.40 yuan/share, and the minimum transaction price was 7.67 yuan/share. The total amount paid was 75,303,968.97 yuan (including transaction fees).
No Data